Season of tumour detection influences factors predicting survival of patients with breast cancer
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 15 (1) , 27-37
- https://doi.org/10.1007/bf01811887
Abstract
The rate of initial detection of breast tumours varies during the year in a seasonal fashion, more tumours being discovered in late spring/early summer than at other times of the year. This phenomenon is particularly pronounced in young women (< 50 years) with progesterone receptor positive tumours. The present study investigates whether season of tumour detection influences the predictive capacity of several recognised prognostic and risk factors in patients with breast cancer. Axillary nodal status, tumour progesterone receptor status, and season of tumour detection significantly influenced survival in both older (> 50 yrs) and younger (< 50 yrs) patients. Parity, lactational history, body mass index, tumour oestrogen receptor status, and patient age also influenced survival, but these effects were significant only in age groups < 50 or > 50 yrs. Season of detection of tumour did not affect the prognostic significance of axillary nodal status. However, the effect of oestrogen receptor status on survival was more significant in patients who detected their tumours in the spring/summer compared with winter (odds ratio 0.52 and 0.73 respectively). Negative progesterone receptor status was associated with significantly poorer survival only in patients with tumours found in the winter. There was a significant survival disadvantage for nulliparous compared with parous women with breast cancer who were ≥ 50 years at diagnosis, and for women who had never lactated compared with those who had lactated, but this disadvantage was restricted to those who found their tumours in the summer. An increased body mass index (≥ 28) was associated with decreased survival, but this was significant only for those detecting tumours in winter. The increased incidence of detection of breast cancer in spring/summer may reflect cyclic influences on tumour growth. Such influences may be hormonal in nature and may underlie the effect of season of tumour detection on the prognostic influence of lactation, parity, body mass index, and oestrogen and progesterone receptor status in patients with breast cancer.This publication has 38 references indexed in Scilit:
- The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1988
- Association between season of first detection of breast cancer and disease progressionBreast Cancer Research and Treatment, 1987
- Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New ZealandBreast Cancer Research and Treatment, 1987
- Long-Term Effect of a First Pregnancy on the Secretion of ProlactinNew England Journal of Medicine, 1987
- The Relation between Survival and Age at Diagnosis in Breast CancerNew England Journal of Medicine, 1986
- Prognostic value of concentration of pregnancy-specific β1-glycoprotein (SP1) in serum of patients with breast cancerInternational Journal of Cancer, 1985
- Seasonal variation in breast cancer detection: Correlation with tumour progesterone receptor statusBreast Cancer Research and Treatment, 1985
- An abnormal early evening peak of plasma prolactin in nulliparous and obese post‐menopausal womenInternational Journal of Cancer, 1978
- Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerPublished by Elsevier ,1972